A comparative analysis of RAS variants in patients with disorders of somatic mosaicism.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
03 2023
Historique:
received: 01 07 2022
revised: 14 11 2022
accepted: 20 11 2022
pubmed: 27 12 2022
medline: 9 3 2023
entrez: 26 12 2022
Statut: ppublish

Résumé

RAS genes (HRAS, KRAS, and NRAS) are commonly found to be mutated in cancers, and activating RAS variants are also found in disorders of somatic mosaicism (DoSM). A survey of the mutational spectrum of RAS variants in DoSM has not been performed. A total of 938 individuals with suspected DoSM underwent high-sensitivity clinical next-generation sequencing-based testing. We investigated the mutational spectrum and genotype-phenotype associations of mosaic RAS variants. In this article, we present a series of individuals with DoSM with RAS variants. Classic hotspots, including Gly12, Gly13, and Gln61 constituted the majority of RAS variants observed in DoSM. Furthermore, we present 12 individuals with HRAS and KRAS in-frame duplication/insertion (dup/ins) variants in the switch II domain. Among the 18.3% individuals with RAS in-frame dup/ins variants, clinical findings were mainly associated with vascular malformations. Hotspots were associated with a broad phenotypic spectrum, including vascular tumors, vascular malformations, nevoid proliferations, segmental overgrowth, digital anomalies, and combinations of these. The median age at testing was higher and the variant allelic fraction was lower in individuals with in-frame dup/ins variants than those in individuals with mosaic RAS hotspots. Our work provides insight into the allelic and clinical heterogeneity of mosaic RAS variants in nonmalignant conditions.

Identifiants

pubmed: 36571464
pii: S1098-3600(22)01036-X
doi: 10.1016/j.gim.2022.11.016
pii:
doi:

Substances chimiques

Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100348

Informations de copyright

Copyright © 2022 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no conflicts of interest.

Auteurs

Ying-Chen Claire Hou (YC)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Michael J Evenson (MJ)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Meagan M Corliss (MM)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Lily Mahapatra (L)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Ali Aldawood (A)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

David F Carpentieri (DF)

Clinical Laboratory, Phoenix Children's Hospital, Phoenix, AZ.

Sarah L Chamlin (SL)

Departments of Pediatrics and Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Division of Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.

Ann M Kulungowski (AM)

Division of Pediatric Surgery, Department of Surgery, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO.

Suneeta Madan-Khetarpal (S)

Division of Medical Genetics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

Jessica Sebastian (J)

Division of Medical Genetics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

Mitchell A Pet (MA)

Division of Plastic and Reconstructive Surgery, Department of Surgery, School of Medicine, Washington University, St. Louis, MO.

Carrie C Coughlin (CC)

Division of Dermatology, Departments of Medicine and Pediatrics, Washington University School of Medicine, St. Louis, MO.

Marcia C Willing (MC)

Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO.

Gregory D Pearson (GD)

Department of Pediatric Plastic and Reconstructive Surgery, Nationwide Children's Hospital, Columbus, OH.

Bhuvana A Setty (BA)

Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH.

Zaki El-Haffaf (Z)

Genetic Medicine Service, Montreal University Hospital (CHUM-CRCHUM), Montréal, Quebec, Canada.

Catherine E Cottrell (CE)

Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH; Department of Pathology, The Ohio State University College of Medicine, Columbus, OH.

Bijal A Parikh (BA)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Kilannin Krysiak (K)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Molly C Schroeder (MC)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.

Jonathan W Heusel (JW)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO; Department of Genetics, Washington University School of Medicine in St. Louis, St. Louis, MO.

Julie A Neidich (JA)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO; Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO.

Yang Cao (Y)

Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO. Electronic address: cao.yang@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH